Related Experiment Video
Updated: Jul 2, 2025

07:54
Two-Step Reverse Transcription Droplet Digital PCR Protocols for SARS-CoV-2 Detection and Quantification
Published on: March 31, 2021
4.6K
Manually pressurized droplet digital PCR chip for rapid SARS-CoV-2 diagnostics
Pinja Elomaa, Tuomas Ojalehto1, Darshan Kumar2
1Aidian Oy, Espoo, Finland.
Biomicrofluidics
|February 29, 2024
Summary
A new portable droplet digital PCR (ddPCR) chip enables rapid, pump-free virus detection. This innovation allows for accurate quantification of viral loads, even at low concentrations, aiding in early disease diagnosis.
Area of Science:
- Biotechnology
- Molecular Diagnostics
- Microfluidics
Background:
- Droplet digital PCR (ddPCR) excels in detecting low viral concentrations, outperforming quantitative real-time PCR (RT-qPCR).
- Early virus detection is crucial for timely diagnosis and treatment.
Purpose of the Study:
- To introduce a novel, portable polydimethylsiloxane (PDMS) ddPCR chip.
- To demonstrate the chip's capability for pump-free, manual operation and AI-powered droplet analysis.
- To validate the chip's performance using a SARS-CoV-2 assay with isothermal strand invasion-based amplification (SIBA).
Main Methods:
- Development of a portable PDMS ddPCR chip operated via manual pressurization.
- Generation of monodispersed droplets in a monolayer for easy imaging.
- Utilizing artificial intelligence for droplet analysis and counting.
- Application of the chip with a SIBA-based SARS-CoV-2 assay.
Main Results:
- The portable ddPCR chip successfully generated monodispersed droplets without external pumps.
- AI-driven analysis enabled efficient droplet counting and quantification.
- The SIBA assay on the ddPCR chip provided accurate viral load approximation for SARS-CoV-2 samples.
- The system demonstrated potential for rapid, point-of-care diagnostics.
Conclusions:
- The novel PDMS ddPCR chip offers a portable and user-friendly platform for microfluidic PCR.
- This technology enables quantitative SIBA assays for virus detection, including SARS-CoV-2.
- The system shows promise for accessible, point-of-care viral diagnostics.

